Cubist Systematic Strategies, LLC - GT BIOPHARMA INC ownership

GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 56 filers reported holding GT BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q2 2023$3,263
-98.6%
10,458
-69.0%
0.00%
-100.0%
Q3 2021$227,00033,7030.00%
Other shareholders
GT BIOPHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Baskin Financial Services Inc. 151,354$470.01%
McCollum Christoferson Group LLC 17,500$5,4600.00%
Moss Adams Wealth Advisors LLC 10,000$3,1200.00%
JANE STREET GROUP, LLC 20,501$6,3960.00%
Cubist Systematic Strategies, LLC 10,458$3,2630.00%
Point72 Asset Management, L.P. 1$00.00%
UBS Group AG 3,033$9460.00%
Compagnie Lombard Odier SCmA 50,000$15,6000.00%
IFP Advisors, Inc 100$2750.00%
OSAIC HOLDINGS, INC. 1,017$3160.00%
View complete list of GT BIOPHARMA INC shareholders